The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) yesterday issued a negative opinion on Gentium SpA's marketing application for defibrotide (Defitelio) for ...
Co announces the presentation of six of preclinical abstracts and posters supporting key mechanism for of Defibrotide in the regulation, inhibition and protection of key regulatory proteins effecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results